Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 1, 1988 - Issue 3
164
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Urinary Risk Factors for Kidney Stones

, Ph.D. (Research Scientist)
Pages 43-52 | Published online: 28 Jan 2018

References

  • Frangos DN, Rous SN:. Incidence and economic factors in urolithiasis, ch. 1. In Rous SN, ed: Stone Disease: Diagnosis and Management. New York, Grune and Stratton, Inc., 1987, pp 3–10.
  • Churchill DN: Medical treatment to prevent recurrent calcium urolithiasis. A guide to critical appraisal. Miner Electrolyte Metab 13: 294–304, 1987.
  • Resnick MI, Pak CYC: Are metabolic studies of urolithiasis necessary? (editorial). J Urol 137: 960–961, 1987.
  • Ljunghall S: Incidence of upper urinary tract stones. Miner Electrolyte Metab 13: 220–227, 1987.
  • Preminger GM, Pak CYC: The practical evaluation and selective medical management of nephrolithiasis. Sent Urol 3: 170–184, 1985.
  • Sakhaee K, Nicar MJ, Glass K, et al: Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism. J Clin Endocrinol Metab 61: 368–373, 1985.
  • Robertson WG, Peacock M, Heyburn PJ, et al: Risk factors in calcium stone disease of the urinary tract. Br J Urol 50: 449–454, 1978.
  • Coe FL: The patient with renal stones, ch 6. In Schrier RW, ed: Manual of Nephrology. Boston, Little, Brown Publishers, 1981, pp 85–97.
  • Menon M, Krishnan CS: Evaluation and medical management of the patient with calcium stone disease. Urol Clin North Am 10: 595–615, 1983.
  • Nicar MJ, Skurla C, Sakhaee K, et al: Low urinary citrate excretion in nephrolithiasis. Urology 21: 8–14, 1983.
  • Pak CYC, Skurla C, Harvey J: Graphic display of urinary risk factors for renal stone formation. J Urol 134: 867–870, 1985.
  • Goldwasser B, Weinerth JL, Carson CC: Calcium stone disease: an overview. J Urol 135: 1–9, 1986.
  • Wasserstein AG, Stolley PD, Soper KA, et al: Case-control study of risk factors for idiopathic calcium nephrolithiasis. Miner Electrolyte Metab 13: 85–95, 1987.
  • Pak CYC: Formation of renal stones may be prevented by restoring normal urinary composition. Proc Eur Dial Transplant Assoc 20: 371–385, 1983.
  • Preminger GM: Pharmacologic treatment of calcium calculi. Urol Clin N Amer 14: 325–333, 1987.
  • Sarig S: The hyperuricosuric calcium oxalate stone former. Miner Electrolyte Metab 13: 251–256, 1987.
  • Strauss AL, Coe FL, Deutsch L, et al: Factors that predict relapse of calcium nephrolithiasis during treatment: a prospective study. Am J Med 72: 17–24, 1982.
  • Drach GW, Perin R, Jacobs S: Outpatient evaluation of patients with calcium urolithiasis. J Urol 121: 564–567, 1979.
  • Halabe A, Sutton RA: Primary hyperparathyroidism and idiopathic hypercalciuria. Miner Electrolyte Metab 13: 235–241, 1987.
  • Robertson WG: Diet and calcium stones. Miner Electrolyte Metab 13: 228–234, 1987.
  • Nicar MJ, Hsu MC, Johnson T, et al: The preservation of urine samples for determination of renal stone risk factors. Lab Med 18: 382–384, 1987.
  • Lemann J Jr, Adams ND, Gray RW: Urinary calcium excretion in human beings. N Eng J Med 301: 535–541, 1979.
  • Werness PG, Brown CM, Smith H, et al: EQUIL 2: A BASIC computer program for the calculation of urinary saturation. J Urol 134: 1242–1244, 1985.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.